logo

Myos Corp (MYOS)



Trade MYOS now with
  Date
  Headline
12/6/2017 6:06:52 AM MYOS RENS Technology Entered Into A Research Agreement
11/14/2017 6:13:05 AM MYOS RENS Tech Q3 Loss Per Share $0.13 Vs Loss $0.17 Last Year
9/20/2017 9:05:42 AM MYOS RENS Technology Enters Employment Agreement With Joseph Mannello To Serve As Its Permanent CEO
4/18/2017 6:09:57 AM MYOS RENS Agrees With Kansas State University To Study Impact Of Fortetropin On Reducing Muscle Loss In Dogs
2/14/2017 6:06:10 PM MYOS RENS Technology Board Adopts Shareholder Rights Plan
3/22/2016 7:35:12 AM MYOS Corporation Announces Corporate Name Change To MYOS RENS Technology Inc.
12/17/2015 8:13:25 AM MYOS Corp Trading Halted; Trading Expected To Resume At 8:30 AM ET
12/17/2015 8:08:11 AM MYOS Announces Strategic Investment By RENS Technology
10/1/2015 8:03:37 AM Cryoport Appoints Robert Hariri To Its Board
5/28/2015 7:35:54 AM MYOS Gets Health Canada Approval Of Proprietary Ingredient Fortetropin
5/26/2015 7:38:00 AM MYOS Corp. Initiates Marketing Plan For Re Muscle Health Products
5/11/2015 7:37:18 AM MYOS Initiates Clinical Study On Fortetropin(R) Dose Response